Apalutamide + ADT for Metastatic Castration-Sensitive Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study
J Urol 2021 Oct 01;206(4)914-923, N Agarwal, K McQuarrie, A Bjartell, S Chowdhury, AJ Pereira de Santana Gomes, BH Chung, M Özgüroğlu, Á Juárez Soto, AS Merseburger, H Uemura, D Ye, R Given, E Basch, B Miladinovic, A Lopez-Gitlitz, KN ChiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.